Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers

被引:32
作者
Liu, Wennuan
Ewing, Charles M.
Chang, Bao-Li
Li, Tao
Sun, Jishan
Turner, Aubrey R.
Dimitrov, Latchezar
Zhu, Yi
Sun, Jielin
Kim, Jin Woo
Zheng, S. Lilly
Isaacs, William B.
Xu, Jianfeng
机构
[1] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27109 USA
[2] Johns Hopkins Med Inst, Baltimore, MD USA
关键词
D O I
10.1002/gcc.20482
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A number of TMPRSS2/ERG fusion transcripts have been reported since the discovery that recurrent genomic rearrangements result in the fusion of TMPRSS2 and ETS family member genes. In this article we present evidence demonstrating that multiple genomic alterations contribute to the formation of various TMPRSS2/ERG transcripts. Using allele-specific analysis of the data generated from the GeneChip 500K SNP array we observed both hemizygous and homozygous deletions occurring at different locations between and within TMPRSS2 and ERG in prostate cancers. The 500K SNP array enabled us to fine map the start and end of each deletion to specific introns of these two genes, and to predict a variety of fusion transcripts, including a new form which was confirmed by sequence analysis of the fusion transcripts in various tumors. We also inferred that translocation is an additional mechanism of fusion for these two genes in some tumors, based on largely diploid genomic DNA between TMPRSS and ERG, and different fusion transcripts produced in these tumors. Using a bioinformatics approach, we then uncovered the consensus sequences in the regions harboring the breakpoints of the deletions. These consensus sequences were homologous to the human Alu-Sq and Alu-Sp subfamily consensus sequences, with more than 80% homology. The presence/absence of Alu family consensus sequence in the introns of TMPRSS2 and ERG correlates with the presence/absence of fusion transcripts of theses two genes, indicating that these consensus sequences may contribute to genomic deletions and the fusion of TMPRSS2 and ERG in prostate cancer. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:972 / 980
页数:9
相关论文
共 25 条
[1]   Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1 [J].
Birger, Y ;
Catez, F ;
Furusawa, T ;
Lim, JH ;
Prymakowska-Bosak, M ;
West, KL ;
Postnikov, YV ;
Haines, DC ;
Bustin, M .
CANCER RESEARCH, 2005, 65 (15) :6711-6718
[2]   Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer [J].
Bova, GS ;
MacGrogan, D ;
Levy, A ;
Pin, SS ;
Bookstein, R ;
Isaacs, WB .
GENOMICS, 1996, 35 (01) :46-54
[3]   TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions [J].
Cerveira, Nuno ;
Ribeiro, Franclim R. ;
Peixoto, Ana ;
Costa, Vera ;
Henrique, Rui ;
Jeronimo, Carmen ;
Teixeira, Manuel R. .
NEOPLASIA, 2006, 8 (10) :826-832
[4]   Diversity of TMPRSS2-ERG fusion transcripts in the human prostate [J].
Clark, J. ;
Merson, S. ;
Jhavar, S. ;
Flohr, P. ;
Edwards, S. ;
Foster, C. S. ;
Eeles, R. ;
Martin, F. L. ;
Phillips, D. H. ;
Crundwell, M. ;
Christmas, T. ;
Thompson, A. ;
Fisher, C. ;
Kovacs, G. ;
Cooper, C. S. .
ONCOGENE, 2007, 26 (18) :2667-2673
[5]   TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort [J].
Demichelis, F. ;
Fall, K. ;
Perner, S. ;
Andren, O. ;
Schmidt, F. ;
Setlur, S. R. ;
Hoshida, Y. ;
Mosquera, J-M ;
Pawitan, Y. ;
Lee, C. ;
Adami, H-O ;
Mucci, L. A. ;
Kantoff, P. W. ;
Andersson, S-O ;
Chinnaiyan, A. M. ;
Johansson, J-E ;
Rubin, M. A. .
ONCOGENE, 2007, 26 (31) :4596-4599
[6]   Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families [J].
Gad, S ;
Caux-Moncoutier, V ;
Pagès-Berhouet, S ;
Gauthier-Villars, M ;
Coupier, I ;
Pujol, P ;
Frénay, M ;
Gilbert, B ;
Maugard, C ;
Bignon, YJ ;
Chevrier, A ;
Rossi, A ;
Fricker, JP ;
Nguyen, TD ;
Demange, L ;
Aurias, A ;
Bensimon, A ;
Stoppa-Lyonnet, D .
ONCOGENE, 2002, 21 (44) :6841-6847
[7]   TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer [J].
Hermans, Karin G. ;
van Marion, Ronald ;
van Dekken, Herman ;
Jenster, Guido ;
van Weerden, Wytske M. ;
Trapman, Jan .
CANCER RESEARCH, 2006, 66 (22) :10658-10663
[8]   A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis [J].
Lapointe, Jacques ;
Kim, Young H. ;
Miller, Melinda A. ;
Li, Chunde ;
Kaygusuz, Gulsah ;
van de Rijn, Matt ;
Huntsman, David G. ;
Brooks, James D. ;
Pollack, Jonathan R. .
MODERN PATHOLOGY, 2007, 20 (04) :467-473
[9]   dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data [J].
Lin, M ;
Wei, LJ ;
Sellers, WR ;
Lieberfarb, M ;
Wong, WH ;
Li, C .
BIOINFORMATICS, 2004, 20 (08) :1233-1240
[10]   Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array [J].
Liu, Wennuan ;
Chang, Baoli ;
Sauvageot, Jurga ;
Dimitrov, Latchezar ;
Gielzak, Marta ;
Li, Tao ;
Yan, Guifang ;
Sun, Jishan ;
Sun, Jielin ;
Adams, Tamara S. ;
Turner, Aubrey R. ;
Kim, Jin Woo ;
Meyers, Deborah A. ;
Zheng, Siqun Lilly ;
Isaacs, William B. ;
Xu, Jianfeng .
GENES CHROMOSOMES & CANCER, 2006, 45 (11) :1018-1032